Literature DB >> 18853091

Athlete's heart or hypertrophic cardiomyopathy?

Jörg Lauschke1, Bernhard Maisch.   

Abstract

Intensive endurance training is able to cause a distinct pattern of functional and structural changes of the cardiovascular system. In an unknown proportion of athletes a so called "athlete's heart" develops. There is an overlap between this type of physiologic cardiac hypertrophy and mild forms of hypertrophic cardiomyopathy (HCM), the most common genetic disorder of the cardiovascular system with a prevalence of 0.2%. HCM is caused by mutations in 14 genes coding for sarcomere proteins. In the literature up to 50% of cases of sudden cardiac death (SCD) in younger sportsmen were connected to hypertrophic cardiomyopathy. It is therefore the most common cause of SCD in highly trained young athletes. Because of this data a great interest in distinguishing these two diagnoses exists. Apart from clinical examination and some non-specific ECG-changes, Echocardiography is the method of choice. The athlete's heart shows an eccentric biventricular hypertrophy with wall thicknesses under 15 mm and a moderately dilated left ventricle (LVEDD up to 58 mm). HCM is commonly characterized by asymmetric left ventricular hypertrophy with a reduced LV-diameter. In up to 70% of cases left ventricular outflow tract obstruction is evident during stress echocardiography. Systolic function is normal in highly trained athletes and the majority of HCM patients as well. There are important differences regarding diastolic filling patterns. Physiological hypertrophy is consistent with a normal diastolic function with even increased early diastolic filling. In case of HCM diastolic dysfunction (mostly relaxation disturbances) occurs in the majority of patients and is therefore inconsistent with an athlete's heart. If the diagnosis could not be stated using echocardiography, methods like cardiac-MRI, metabolic exercise testing, histological studies of endomyocardial biopsies and genetic testing can provide further information. A correct diagnosis may on the one hand prevent some athletes from sudden cardiac death. On the other hand sportsmen with an athlete's heart are reassured and able to continue as competitors. New insights into electrophysiological changes during physiological hypertrophy could probably change this view.

Entities:  

Mesh:

Year:  2008        PMID: 18853091     DOI: 10.1007/s00392-008-0721-2

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  37 in total

Review 1.  Cardiomyopathy: The diagnosis of hypertrophic cardiomyopathy.

Authors:  E D Wigle
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

Review 2.  Physical activity, physical fitness, and sudden cardiac death.

Authors:  H W Kohl; K E Powell; N F Gordon; S N Blair; R S Paffenbarger
Journal:  Epidemiol Rev       Date:  1992       Impact factor: 6.222

3.  Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.

Authors:  Perry M Elliott; Juan R Gimeno; María T Tomé; Jaymin Shah; Deirdre Ward; Rajesh Thaman; Jens Mogensen; William J McKenna
Journal:  Eur Heart J       Date:  2006-06-05       Impact factor: 29.983

4.  Sarcomeric genotyping in hypertrophic cardiomyopathy.

Authors:  Sara L Van Driest; Steve R Ommen; A Jamil Tajik; Bernard J Gersh; Michael J Ackerman
Journal:  Mayo Clin Proc       Date:  2005-04       Impact factor: 7.616

5.  Prognostic value of intra-left ventricular electromechanical asynchrony in patients with mild hypertrophic cardiomyopathy compared with power athletes.

Authors:  A D'Andrea; P Caso; S Cuomo; G Salerno; R Scarafile; C Mita; G De Corato; B Sarubbi; M Scherillo; R Calabrò
Journal:  Br J Sports Med       Date:  2006-03       Impact factor: 13.800

6.  Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; T J Anan; W C Roberts
Journal:  Circulation       Date:  1981-04       Impact factor: 29.690

7.  Physiological left ventricular hypertrophy or hypertrophic cardiomyopathy in an elite adolescent athlete: role of detraining in resolving the clinical dilemma.

Authors:  S Basavarajaiah; M Wilson; S Junagde; G Jackson; G Whyte; S Sharma; W O Roberts
Journal:  Br J Sports Med       Date:  2006-08       Impact factor: 13.800

Review 8.  Structural features of the athlete heart as defined by echocardiography.

Authors:  B J Maron
Journal:  J Am Coll Cardiol       Date:  1986-01       Impact factor: 24.094

Review 9.  Sudden cardiac death and the 'athlete's heart'.

Authors:  J N Wight; D Salem
Journal:  Arch Intern Med       Date:  1995-07-24

Review 10.  Exercise-induced cardiac hypertrophy: a substrate for sudden death in athletes?

Authors:  G Hart
Journal:  Exp Physiol       Date:  2003-09       Impact factor: 2.969

View more
  29 in total

1.  Correlation between ECG abnormalities and cardiac parameters in highly trained asymptomatic male endurance athletes: evaluation using cardiac magnetic resonance imaging.

Authors:  Gunnar Erz; Stefanie Mangold; Erik Franzen; Claus D Claussen; Andreas M Niess; Christof Burgstahler; Ulrich Kramer
Journal:  Int J Cardiovasc Imaging       Date:  2012-06-22       Impact factor: 2.357

Review 2.  Influence of Physical Activity on Hypertension and Cardiac Structure and Function.

Authors:  Sheila M Hegde; Scott D Solomon
Journal:  Curr Hypertens Rep       Date:  2015-10       Impact factor: 5.369

3.  Re: Athlete's heart or hypertrophic cardiomyopathy?

Authors:  Horst Kuhn
Journal:  Clin Res Cardiol       Date:  2009-06-09       Impact factor: 5.460

4.  Pitfalls in the differentiation between athlete's heart and hypertrophic cardiomyopathy.

Authors:  Jürgen Scharhag; Wilfried Kindermann
Journal:  Clin Res Cardiol       Date:  2009-07       Impact factor: 5.460

5.  Echocardiographic measurements of the right ventricle: right ventricular outflow tract 1.

Authors:  K Loiske; S Hammar; K Emilsson
Journal:  Clin Res Cardiol       Date:  2010-03-07       Impact factor: 5.460

6.  Screening of sarcomere gene mutations in young athletes with abnormal findings in electrocardiography: identification of a MYH7 mutation and MYBPC3 mutations.

Authors:  Chika Kadota; Takuro Arimura; Takeharu Hayashi; Taeko K Naruse; Sachio Kawai; Akinori Kimura
Journal:  J Hum Genet       Date:  2015-07-16       Impact factor: 3.172

7.  Comparison of morphological and functional adaptations of the heart in highly trained triathletes and long-distance runners using cardiac magnetic resonance imaging.

Authors:  Erik Franzen; Stefanie Mangold; Gunnar Erz; Claus D Claussen; Andreas M Niess; Ulrich Kramer; Christof Burgstahler
Journal:  Heart Vessels       Date:  2012-09-15       Impact factor: 2.037

8.  1H- and 31P-myocardial magnetic resonance spectroscopy in non-obstructive hypertrophic cardiomyopathy patients and competitive athletes.

Authors:  Francesco Secchi; Giovanni Di Leo; Marcello Petrini; Riccardo Spairani; Marco Alì; Marco Guazzi; Francesco Sardanelli
Journal:  Radiol Med       Date:  2017-01-09       Impact factor: 3.469

Review 9.  MYBPC3's alternate ending: consequences and therapeutic implications of a highly prevalent 25 bp deletion mutation.

Authors:  Diederik W D Kuster; Sakthivel Sadayappan
Journal:  Pflugers Arch       Date:  2013-12-11       Impact factor: 3.657

10.  Early repolarization syndrome: a decade of progress.

Authors:  Ihor Gussak; Charles Antzelevitch
Journal:  J Electrocardiol       Date:  2013 Mar-Apr       Impact factor: 1.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.